ELAN Elanco Animal Health Inc

Price (delayed)

$33.70

Market cap

$15.94B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.25

Enterprise value

$21.59B

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
Elanco Animal Health's revenue has increased by 29% YoY and by 18% from the previous quarter
The gross profit has grown by 27% YoY and by 22% from the previous quarter
The quick ratio has plunged by 71% YoY but it has grown by 7% from the previous quarter
ELAN's equity is up by 20% YoY but it is down by 6% from the previous quarter
The debt has soared by 199% year-on-year
Elanco Animal Health's net income has decreased by 2.1% from the previous quarter

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
473M
Market cap
$15.94B
Enterprise value
$21.59B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.99
Price to sales (P/S)
4.25
EV/EBIT
N/A
EV/EBITDA
146.35
EV/Sales
5.6
Earnings
Revenue
$3.86B
EBIT
-$489.9M
EBITDA
$147.5M
Free cash flow
-$240.1M
Per share
EPS
-$1.25
Free cash flow per share
-$0.49
Book value per share
$16.96
Revenue per share
$7.93
TBVPS
$10.15
Balance sheet
Total assets
$16.99B
Total liabilities
$8.98B
Debt
$6.16B
Equity
$8.01B
Working capital
$1.31B
Liquidity
Debt to equity
0.77
Current ratio
1.64
Quick ratio
0.81
Net debt/EBITDA
38.28
Margins
EBITDA margin
3.8%
Gross margin
50.7%
Net margin
-14.8%
Operating margin
-12.7%
Efficiency
Return on assets
-3.7%
Return on equity
-7.3%
Return on invested capital
-6.5%
Return on capital employed
-3.3%
Return on sales
-12.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
0.33%
1 week
-1.4%
1 month
4.3%
1 year
55.51%
YTD
9.88%
QTD
14.43%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$3.86B
Gross profit
$1.95B
Operating income
-$491M
Net income
-$572M
Gross margin
50.7%
Net margin
-14.8%
Elanco Animal Health's revenue has increased by 29% YoY and by 18% from the previous quarter
The gross profit has grown by 27% YoY and by 22% from the previous quarter
The company's operating margin rose by 21% QoQ
The net margin is up by 13% since the previous quarter

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
P/E
N/A
P/B
1.99
P/S
4.25
EV/EBIT
N/A
EV/EBITDA
146.35
EV/Sales
5.6
The price to book (P/B) is 33% higher than the last 4 quarters average of 1.5
ELAN's equity is up by 20% YoY but it is down by 6% from the previous quarter
Elanco Animal Health's revenue has increased by 29% YoY and by 18% from the previous quarter
ELAN's P/S is 9% above its last 4 quarters average of 3.9

Efficiency

How efficient is Elanco Animal Health business performance
The company's return on sales rose by 21% QoQ
Elanco Animal Health's ROIC has increased by 20% from the previous quarter
The company's return on assets rose by 10% QoQ

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 89% higher than its total liabilities
The company's total liabilities has surged by 193% YoY but it fell by 2.6% QoQ
Elanco Animal Health's total assets has surged by 75% YoY but it has decreased by 4% QoQ
The debt is 23% smaller than the equity
The debt has soared by 199% year-on-year
The debt to equity has surged by 148% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.